Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries... Show more
Mettler-Toledo International maintains global leadership in precision instruments, holding number-one market positions in key categories like laboratory balances, pipettes, and analytical sensors. Its diversified end-markets—spanning life sciences (pharma/biotech), industrial process control, and food retail—weaken cyclical risks. Competitive moats include a robust direct sales and service network, enabling recurring revenue from maintenance contracts that now form a growing portion of sales. Innovation cycles, such as automation-integrated solutions and digitalization tools, support medium-term share gains. Expansion into high-growth regions like India and Southeast Asia targets lab infrastructure buildouts projected at 8% annual growth. While peers like Thermo Fisher compete broadly, MTD's focus on high-precision niches and superior operating margins (over 30%) underscore structural resilience.
The Q1 2026 earnings release on May 7, followed by the conference call on May 8, represents the nearest catalyst, with consensus EPS at $8.70 and potential updates to full-year guidance. Investors will scrutinize commentary on segment momentum and tariff impacts. Subsequent events, including the BofA Securities Healthcare Conference on May 13, could yield strategic insights. Ongoing share buybacks, which bolstered returns in 2025, remain a supportive factor. Analyst revisions have been mixed, with recent adjustments like Morgan Stanley's $1,475 target reflecting cautious optimism; consensus trends show stable Buy/Hold distributions without major shifts. Product launches in low-emission materials and AI-enhanced weighing systems could further catalyze sentiment if timed with industry shifts toward sustainability.
The precision instruments sector benefits from tailwinds in pharmaceutical R&D, food safety regulations, and industrial automation, with lab equipment markets eyeing 4-5% CAGR through 2030. MTD's exposure amplifies upside from biotech funding and onshoring trends but heightens sensitivity to capex deferrals amid elevated interest rates. Inflation in commodities could squeeze input costs, though pricing power mitigates this. Geopolitical risks loom large, particularly U.S.-China trade tensions affecting 15-20% of sales, alongside FX headwinds from a strong USD. Broader adoption of IoT and AI in labs aligns with MTD's pipeline, positioning it to capture digital transformation spend. Regulatory pushes for sustainability, including EU CSRD compliance, favor its GreenMT initiatives targeting Scope 1/2 emissions cuts by 2030.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying potential bullish, bearish, or sideways movements for stocks, ETFs, and other assets over the next week or month. By analyzing vast datasets, it spots emerging trends, evaluates breakout or reversal signals, and provides predictions across thousands of tradable instruments. Features include searchable categories by timeframe, historical performance context, and customizable alerts for real-time opportunities. This neutral, data-driven approach empowers users to make informed decisions amid market volatility. Explore the Trend Prediction Engine to enhance your trading strategy today.
For 2026, management guides 4% LC sales growth, with adjusted EPS of $46.05-$46.70, reflecting resilient demand despite cautious customer spending. Service revenue acceleration and operational efficiencies should sustain high-20s margins. Long-term, watch market expansion in emerging Asia, cost evolution via supply chain onshoring, and margin uplift from digital services. Technology transitions like AI/IoT integration promise innovation leadership, though competitive pressures from diversified giants persist. Regulatory developments in ESG reporting and trade policies could reshape dynamics. Consensus analyst expectations align with mid-teens price target upside, emphasizing durable growth over 10% EPS CAGR potential. Capital allocation prioritizes buybacks and bolt-on M&A to compound returns.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a manufacturer of precision instruments
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | +1.36% | ||
| A - MTD | 71% Closely correlated | +2.20% | ||
| TMO - MTD | 67% Closely correlated | +0.63% | ||
| BRKR - MTD | 67% Closely correlated | +4.57% | ||
| DHR - MTD | 63% Loosely correlated | -0.33% | ||
| AZTA - MTD | 61% Loosely correlated | +2.80% | ||
More | ||||
MTD broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 44 similar instances where the stock broke above the upper band. In of the 44 cases the stock fell afterwards. This puts the odds of success at .
The Momentum Indicator moved below the 0 level on June 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MTD as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MTD entered a downward trend on May 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MTD's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where MTD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MTD just turned positive on May 27, 2026. Looking at past instances where MTD's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MTD advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MTD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (12.525). P/E Ratio (26.893) is within average values for comparable stocks, (146.277). Projected Growth (PEG Ratio) (2.401) is also within normal values, averaging (1.492). MTD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.008). P/S Ratio (5.744) is also within normal values, averaging (7.403).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.